Young‐Chae Chang
Impact in
- Pharmacology top 0.5%
- Healthcare and Venom Research
- Cancer Research top 2%
Papers in
-
- Ubiquitin and proteasome pathways 10
- Genomics, phytochemicals, and oxidative stress 8
- Pharmacology 34
- Healthcare and Venom Research 23
- Co-authors
- Cheorl‐Ho Kim (70 shared papers)Kwan‐Kyu Park (45 shared papers)Yun‐Jeong Jeong (34 shared papers)Junji Magae (37 shared papers)Yung Hyun Choi (28 shared papers)Hyun-Ji Cho (20 shared papers)Wun‐Jae Kim (15 shared papers)Hyeun‐Wook Chang (19 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (14 papers)Journal of Cellular Biochemistry (10 papers)Journal of Ethnopharmacology (8 papers)International Journal of Molecular Sciences (6 papers)International Immunopharmacology (6 papers)
- Partner nations
- South KoreaJapanUnited States
In The Last Decade
Young‐Chae Chang
154 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 120
- Pharmacology 878
- Cancer Research 565
- Insect Science 436
- Toxicology 104
- Molecular Biology 2.1k
Countries citing papers authored by Young‐Chae Chang
This map shows the geographic impact of Young‐Chae Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young‐Chae Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young‐Chae Chang more than expected).
Fields of papers citing papers by Young‐Chae Chang
This network shows the impact of papers produced by Young‐Chae Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young‐Chae Chang. The network helps show where Young‐Chae Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Young‐Chae Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 178 | |
| 2 | mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway. | 1998 | 135 |
| 3 | 2005 | 118 | |
| 4 | 2014 | 115 | |
| 5 | 2012 | 109 | |
| 6 | 2014 | 104 | |
| 7 | 2007 | 101 | |
| 8 | 2015 | 92 | |
| 9 | 2010 | 91 | |
| 10 | 2011 | 88 | |
| 11 | 2016 | 82 | |
| 12 | 2007 | 82 | |
| 13 | 2017 | 80 | |
| 14 | 2013 | 71 | |
| 15 | 2016 | 70 | |
| 16 | 2006 | 63 | |
| 17 | 2010 | 62 | |
| 18 | 2001 | 61 | |
| 19 | 1988 | 61 | |
| 20 | 2013 | 59 |
About Young‐Chae Chang
Young‐Chae Chang is a scholar working on Molecular Biology, Pharmacology, Cancer Research, Oncology and Epidemiology, having authored 154 papers that have together received 4.5k indexed citations. Recurring topics across this work include Healthcare and Venom Research (23 papers), Cancer-related Molecular Pathways (16 papers), Autophagy in Disease and Therapy (15 papers), Bee Products Chemical Analysis (14 papers), Cancer, Hypoxia, and Metabolism (14 papers), Ubiquitin and proteasome pathways (10 papers), NF-κB Signaling Pathways (9 papers) and Genomics, phytochemicals, and oxidative stress (8 papers). The work is most often cited by research in Pharmacology (878 citations), Cancer Research (565 citations), Insect Science (436 citations), Toxicology (104 citations) and Molecular Biology (2.1k citations). Young‐Chae Chang has collaborated with scholars based in South Korea, Japan and United States. Frequent co-authors include Cheorl‐Ho Kim, Kwan‐Kyu Park, Yun‐Jeong Jeong, Junji Magae, Yung Hyun Choi, Hyun-Ji Cho, Wun‐Jae Kim, Hyeun‐Wook Chang, Yoon-Yub Park and Nicholas H. Heintz. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Cellular Biochemistry, Journal of Ethnopharmacology, International Journal of Molecular Sciences and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.